Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

JPIAMR: How do we simultaneously manage the acute COVID-19 pandemic and escalating antibiotic resistance?

On September 18, Government Engagement and Policy Manager Margo Warren will join the final webinar of JPIAMR's "AMR research in a post-pandemic world" series. This session will focus on the ways in which knowledge and behaviours gained from the COVID-19 pandemic can help create and sustain awareness and action to address AMR.

Date

18 September 2020

Update: You can watch the webinar recording here.

Margo Warren, Government Engagement and Policy Manager for the Access to Medicine Foundation, will join this webinar to discuses:

  • The COVID-19 pandemic has created awareness of infection biology and a wider community understanding of infection prevention and control. How can we build on this knowledge to support understanding of antimicrobial resistance (AMR)?

  • Funding and policy efforts are currently highly focused on COVID-19. What do clinical and scientific communities need to do to continue to raise awareness about AMR?

Other panelists in the webinar include: 

  • Charu Kaushic (GloPID-R) 

  • Steven Hoffman (Global Strategy Lab)

  • Ghada Zoubiane (ICARS)

  • Sabiha Essack (University of KwaZulu-Natal)

  • Otto Cars (ReAct)

  • Ramanan Laxminarayan (CDDEP & Princeton University)

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved